(ADP-ribose) polymerase 1 and AMP-activated protein kinase mediate progressive dopaminergic neuronal degeneration in a mouse model of Parkinson’s disease
出版年份 2013 全文链接
标题
(ADP-ribose) polymerase 1 and AMP-activated protein kinase mediate progressive dopaminergic neuronal degeneration in a mouse model of Parkinson’s disease
作者
关键词
-
出版物
Cell Death & Disease
Volume 4, Issue 11, Pages e919-e919
出版商
Springer Nature
发表日期
2013-11-14
DOI
10.1038/cddis.2013.447
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The CAMKK2-AMPK Kinase Pathway Mediates the Synaptotoxic Effects of Aβ Oligomers through Tau Phosphorylation
- (2013) Georges Mairet-Coello et al. NEURON
- Multiple Defects in Energy Metabolism in Alzheimers Disease
- (2012) I. L. Ferreira et al. CURRENT DRUG TARGETS
- Dopaminergic pathway reconstruction by Akt/Rheb-induced axon regeneration
- (2011) Sang Ryong Kim et al. ANNALS OF NEUROLOGY
- Nuclear translocation of AMPK-α1 potentiates striatal neurodegeneration in Huntington’s disease
- (2011) Tz-Chuen Ju et al. JOURNAL OF CELL BIOLOGY
- AAV Transduction of Dopamine Neurons With Constitutively Active Rheb Protects From Neurodegeneration and Mediates Axon Regrowth
- (2011) Sang Ryong Kim et al. MOLECULAR THERAPY
- AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1
- (2011) Joungmok Kim et al. NATURE CELL BIOLOGY
- AMP-activated protein kinase: nature's energy sensor
- (2011) David Carling et al. Nature Chemical Biology
- Mitochondria: The Next (Neurode)Generation
- (2011) Eric A. Schon et al. NEURON
- Visualization of Spatiotemporal Energy Dynamics of Hippocampal Neurons by Mass Spectrometry during a Kainate-Induced Seizure
- (2011) Yuki Sugiura et al. PLoS One
- Dissociation of Progressive Dopaminergic Neuronal Death and Behavioral Impairments by Bax Deletion in a Mouse Model of Parkinson's Diseases
- (2011) Tae Woo Kim et al. PLoS One
- Poly(ADP-Ribose) (PAR) Binding to Apoptosis-Inducing Factor Is Critical for PAR Polymerase-1-Dependent Cell Death (Parthanatos)
- (2011) Y. Wang et al. Science Signaling
- BH3 Domains other than Bim and Bid Can Directly Activate Bax/Bak
- (2010) Han Du et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- AMP kinase–mediated activation of the BH3-only protein Bim couples energy depletion to stress-induced apoptosis
- (2010) Caoimhín G. Concannon et al. JOURNAL OF CELL BIOLOGY
- An energy systems approach to Parkinson's disease
- (2010) Peter Wellstead et al. Wiley Interdisciplinary Reviews-Systems Biology and Medicine
- Parkin-induced mitophagy in the pathogenesis of Parkinson disease
- (2009) Derek Narendra et al. Autophagy
- Expanding roles for AMP-activated protein kinase in neuronal survival and autophagy
- (2009) Jeroen Poels et al. BIOESSAYS
- Combination therapy with Coenzyme Q10and creatine produces additive neuroprotective effects in models of Parkinson’s and Huntington’s Diseases
- (2009) Lichuan Yang et al. JOURNAL OF NEUROCHEMISTRY
- AMPK in the brain: its roles in energy balance and neuroprotection
- (2009) Gabriele V. Ronnett et al. JOURNAL OF NEUROCHEMISTRY
- Antidiabetic drug metformin (GlucophageR) increases biogenesis of Alzheimer's amyloid peptides via up-regulating BACE1 transcription
- (2009) Y. Chen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PINK1-dependent recruitment of Parkin to mitochondria in mitophagy
- (2009) C. Vives-Bauza et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Role of AMP-activated protein kinase in autophagy and proteasome function
- (2008) Rosa Viana et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- AMPK Phosphorylation of Raptor Mediates a Metabolic Checkpoint
- (2008) Dana M. Gwinn et al. MOLECULAR CELL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started